Home › Sickle Cell Disease › Texas
Sickle Cell Disease clinical trials in Texas
11 studies for Sickle Cell Disease are looking for participants at sites in Texas.
Cities in Texas
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 28, 2026 · NCT06439082A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 18, 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- UT Health University of Texas, Houston
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- UT Health Science Center, Houston
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 55 · All sexes · Updated Sep 9, 2026 · NCT06546670ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Blood and Cancer Center of Central Texas, Austin
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Baylor College of Medicine- Site Number : 8400055, Houston
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Jul 29, 2026 · NCT06975865Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
- UT San Antonio (NT-DMT), San Antonio
RecruitingObservational study
Ages 3 to 20 · All sexes · Updated Jun 4, 2026 · NCT06941389Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400004, Houston
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Apr 15, 2026 · NCT07247188Sickle Cell Kidney Biorepository
- Parkland Memorial Hospital, Dallas
- University of Texas Southwestern Medical Center, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Apr 13, 2026 · NCT07064174Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Baylor College of Medicine, Houston
RecruitingPhase 2
Ages 15 to 40 · All sexes · Updated Mar 13, 2026 · NCT06260891Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Texas at Houston, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 22, 2025 · NCT06385886From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.